X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (38) 38
index medicus (33) 33
hematology (27) 27
multiple myeloma (23) 23
female (21) 21
male (21) 21
middle aged (21) 21
multiple myeloma - drug therapy (21) 21
aged (17) 17
oncology (16) 16
adult (15) 15
bortezomib (14) 14
stem-cell transplantation (13) 13
multiple myeloma - therapy (12) 12
thalidomide (12) 12
treatment outcome (12) 12
chemotherapy (10) 10
multiple myeloma - genetics (10) 10
multiple myeloma - mortality (10) 10
prognosis (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
dexamethasone (9) 9
multiple myeloma - diagnosis (9) 9
aged, 80 and over (8) 8
remission induction (8) 8
abridged index medicus (7) 7
antineoplastic agents - therapeutic use (7) 7
disease-free survival (7) 7
survival (7) 7
survival analysis (7) 7
thalidomide - therapeutic use (7) 7
transplantation, autologous (7) 7
cancer (6) 6
disease progression (6) 6
lenalidomide (6) 6
multiple myeloma - complications (6) 6
thalidomide - administration & dosage (6) 6
therapy (6) 6
autologous transplantation (5) 5
combined modality therapy (5) 5
consolidation therapy (5) 5
dexamethasone - administration & dosage (5) 5
follow-up studies (5) 5
induction therapy (5) 5
retrospective studies (5) 5
trial (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
development and progression (4) 4
dexamethasone - adverse effects (4) 4
dexamethasone - therapeutic use (4) 4
fluorodeoxyglucose f18 (4) 4
immunoglobulin light chains - blood (4) 4
lenalidomide plus dexamethasone (4) 4
maintenance (4) 4
multiple myeloma - immunology (4) 4
multiple-myeloma (4) 4
myeloma (4) 4
peripheral neuropathy (4) 4
plus dexamethasone (4) 4
stem cell transplantation (4) 4
thalidomide - adverse effects (4) 4
translocation, genetic (4) 4
transplantation (4) 4
abnormalities (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
boronic acids - administration & dosage (3) 3
care and treatment (3) 3
genetic aspects (3) 3
hematology, oncology and palliative medicine (3) 3
hematopoietic stem cell transplantation - methods (3) 3
hemic and lymphatic diseases (3) 3
in situ hybridization, fluorescence (3) 3
induction chemotherapy (3) 3
intraclonal heterogeneity (3) 3
kaplan-meier estimate (3) 3
magnetic resonance imaging (3) 3
medicine & public health (3) 3
models, biological (3) 3
monoclonal gammopathy (3) 3
multiple myeloma - blood (3) 3
multiple myeloma - diagnostic imaging (3) 3
multiple myeloma - metabolism (3) 3
multiple myeloma - pathology (3) 3
multiple myeloma - physiopathology (3) 3
neoplasm staging (3) 3
positron-emission tomography (3) 3
positron-emission-tomography (3) 3
progression (3) 3
prospective studies (3) 3
proteasome inhibitors (3) 3
proteins (3) 3
pyrazines - administration & dosage (3) 3
randomized controlled-trial (3) 3
recurrence (3) 3
risk factors (3) 3
thalidomide - analogs & derivatives (3) 3
tomography, x-ray computed (3) 3
toxicity (3) 3
young adult (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 05/2014, Volume 165, Issue 4, pp. 441 - 454
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 07/2012, Volume 120, Issue 1, pp. 9 - 19
Journal Article
Annals of Hematology, ISSN 0939-5555, 03/2019, Volume 98, Issue 3, pp. 713 - 722
Journal Article
American Journal of Hematology, ISSN 0361-8609, 07/2015, Volume 90, Issue 7, pp. 647 - 652
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4625 - 4625
Abstract Introduction MEL at the dose of 200 mg/m2 (MEL200) is considered the standard conditioning regimen before ASCT in MM patients (pts). Lower doses of... 
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 2014, Volume 14, Issue 5, pp. 581 - 594
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2009, Volume 27, Issue 30, pp. 5001 - 5007
Journal Article